Private Placement

Facing critical staff shortages, Rochester Regional Health offers up to $180,000 in loan relief to secure vital healthcare roles for the community.

NewLake Capital's CEO joins a top panel, signaling growing acceptance of cannabis real estate as a resilient asset in a volatile investment landscape.

A new one-time gene therapy shows it can clear toxic brain plaques in preclinical studies, offering a potential path to halt or even reverse Alzheimer's.

The company advances a new transport system for advanced reactor fuel, a crucial step in a competitive race to build the future nuclear supply chain.

From a family brewery and a personal health journey to the national stage, see how Beer Girl's founder is shaking up the beer industry on Shark Tank.

A landmark partnership between Realta Fusion and Kyoto Fusioneering merges American physics with Japanese engineering to accelerate the path to commercial fusion.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

A new $100M credit facility aims to inject liquidity into the housing market, highlighting the growing role of institutional finance in single-family rentals.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

Red Bull Basement 2026 is open, challenging founders to build startups with AI, offering a $100k prize and a path from idea to the global stage.

VNET smashes 2025 revenue goals on AI demand, but a net loss and huge capex plan raise questions about its high-stakes growth strategy in China.

Pilgrim’s 'Nani Ka Secret' campaign, with Rashmika Mandanna, blends tradition and K-beauty science, fueling its rapid rise in India's beauty market.

Domestic Metals completes a key survey at its Smart Creek project, setting the stage for a Q2 drill campaign amid a booming metals market.

A DIY system promises water from thin air amid global uncertainty. We investigate if the Joseph's Well program is a real solution or just hot air.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

With a new strategic finance leader, MATEREAL signals a shift from R&D to aggressive commercialization of its 'drop-in' AI-enabled bio-polymers.

A European firm is bringing passive brain-computer interface tech to the US, promising safer AI but raising profound questions about mental privacy.

Genspark.ai launches its first 'AI employee,' crossing a $200M run rate and securing a $1.6B valuation in the race to automate knowledge work.

Rivian unveils the R2, a mid-size SUV starting around $45,000. It packs clever features and impressive range, but can the company scale production to meet demand?